References
- Shiao CC, Kao TW, Hung KY, et al. Seven-year follow-up of peritoneal dialysis patients in Taiwan. Perit Dial Int. 2009;29:450–457
- Portolés J, Corchete E, López-Sánchez P, et al. Patients on peritoneal dialysis with type 2 diabetes present poorer progress than non-diabetics at the expense of their cardiovascular comorbidity. Nefrologia. 2009;29:336–342
- García-López E, Carrero JJ, Suliman ME, Lindholm B, Stenvinkel P. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int. 2007;27:s205–s209
- Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008;51:s1–s320
- Saha H, Leskinen Y, Salenius P, Lahtela T. Peripheral vascular disease in diabetic peritoneal dialysis patients. Perit Dial Int. 2007;27:s211–s214
- Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int. 2005;25:374–379
- Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis. 2005;45:372–380
- Han SH, Lee SC, Ahn SV, et al. Improving outcome of CAPD: twenty-five years’ experience in a single Korean center. Perit Dial Int. 2007;27:432–340
- Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol. 2009;4:1195–2000
- Golper TA, Brier ME, Bunke M, et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis. 1996;28:428–436
- Rodríguez-Carmona A, Pérez Fontán M, García Falcón T, Fernández Rivera C, Valdés F. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int. 1999;19:253–258
- de Fijter CW, Oe LP, Nauta JJ, et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med. 1994;120:264–271
- Ono K, Tsuchida A, Kawai H, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol. 2003;14:1591–1598
- Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis. 1996;27:668–672
- Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull. 1987;17:138
- Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207–1213
- Gloor HJ. 20 years of peritoneal dialysis in a mid-sized Swiss hospital. Swiss Med Wkly. 2003;133:619–624
- USRDS: the United States Renal Data System. Am J Kidney Dis. 2003;42:s1–s230
- Shinzato T, Nakai S, Akiba T, et al. Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant. 1997;12:889–898
- Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int. 2006;70:55–62
- Li PK, Law MC, Chow KM, et al. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study. Am J Kidney Dis. 2002;40:373–380
- Kim DK, Yoo TH, Ryu DR, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center’s experience over one decade. Perit Dial Int. 2004;24:424–432
- Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis - associated peritonitis in Scotland (1999–2002). Nephrol Dial Transplant. 2004;19:2584–2591
- Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int. 2009;29:297–302
- Johnson D, Excell L, Livingston B, Bannister K, McDonald S. Chapter 6: peritoneal dialysis. In: McDonald S, Excell L, Livingston B, eds. The Thirty First Report-Australia and New Zealand Dialysis and Transplant Registry: 2008. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2008:6-1–6-20. Available at: http://www.anzdata.org.au/v1/report-2008.html. Accessed March 15, 2013
- Martin C, Montes R, Guerrero A, Lopez R, Cabello V, Bernal G. Peripheral vascular disease in CAPD. Perit Dial Int. 1996;16:529–531
- Lestinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis. 2002;40:472–579
- Fung F, Sherrard DJ, Gillen DL, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis. 2002;40:307–314
- Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM. Body mass index and peritoneal dialysis: “exceptions to the exception” in reverse epidemiology? Semin Dial. 2007;20:561–565
- Zhou H, Cui L, Zhu G, et al. Survival advantage of normal weight in peritoneal dialysis patients. Ren Fail. 2011;33(10):964–968
- Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011;6:1041–1048
- Chen KH, Lin JL, Lin-Tan DT, et al. Glycated hemoglobin predicts mortality in nondiabetic patients receiving chronic peritoneal dialysis. Am J Nephrol. 2010;32:567–574
- Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–811
- Sharif A, Baboolal K. Diagnostic application of the A[1c] assay in renal disease. J Am Soc Nephrol. 2010;21:383–385